UCL Cancer Institute

Cancer, microRNAs, and other non-coding RNAs

12th September 2012 , Darwin Lecture Theatre, University College London


Frank Slack – Yale University, USA

Joshua Mendell – UT Southwestern Medical Center, USA

Javier Caceres – MRC Human Genetics Unit, UK

Andrea Califano – Columbia University, USA

Eric Miska – Gurdon Institute, UK

Ranit Aharonov – Rosetta Genomics, Israel

Judy Lieberman – Harvard University, USA

Martin Bushell – University of Leicester, UK

Conference poster availble here. Registration details will be available shortly.

Non-coding RNAs and Cancer

Tuesday 12th April 2011, Beveridge Hall, University of London Senate House.

The study of microRNAs and long non-coding RNAs has revolutionised our understanding of gene expression regulation during cancer development and progression, creating one of the fastest growing research fields in cancer with realistic therapeutic potential. The UCL Cancer Institute is hosting an international one-day symposium highlighting the function and regulation of non-coding RNAs during oncogenesis. The symposium will cover a wide range of themes, from the basic biology of the RNA silencing machinery to clinical applications of microRNA antagonists, and from the function of small RNAs in transcription to the delineation of functional networks of small RNAs and RNA-binding proteins in development, immunity, and cancer. Overall, we aim to create an inspiring interactive forum for basic and clinician scientists working on non-coding RNAs and cancer.

 View PDF version.

MicroRNAs and Cancer

Tuesday 16th February 2010, Darwin Lecture Theatre, Darwin Building, UCL

Following the discovery of the first endogenous small non-coding silencing RNA in 1993, the study of microRNAs has revolutionised our understanding of gene expression regulation during development, immunity, and pathogenesis. The UCL Cancer Institute is hosting an international symposium highlighting the function and regulation of microRNAs during oncogenesis. Invited talks are from scientists who have contributed seminal discoveries to the field of “microRNAs and Cancer”, as well as novel exciting research of high biological and clinical relevance.